2rnd

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (12:54, 20 December 2023) (edit) (undo)
 
Line 1: Line 1:
==Structure of the N-terminal BARpeptide in DPC micelles==
==Structure of the N-terminal BARpeptide in DPC micelles==
-
<StructureSection load='2rnd' size='340' side='right'caption='[[2rnd]], [[NMR_Ensembles_of_Models | 10 NMR models]]' scene=''>
+
<StructureSection load='2rnd' size='340' side='right'caption='[[2rnd]]' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[2rnd]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Human Human]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2RND OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2RND FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[2rnd]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2RND OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2RND FirstGlance]. <br>
-
</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat"><div style='overflow: auto; max-height: 3em;'>[[2rmy|2rmy]]</div></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2rnd FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2rnd OCA], [https://pdbe.org/2rnd PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2rnd RCSB], [https://www.ebi.ac.uk/pdbsum/2rnd PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2rnd ProSAT]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2rnd FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2rnd OCA], [https://pdbe.org/2rnd PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2rnd RCSB], [https://www.ebi.ac.uk/pdbsum/2rnd PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2rnd ProSAT]</span></td></tr>
</table>
</table>
== Disease ==
== Disease ==
-
[[https://www.uniprot.org/uniprot/BIN1_HUMAN BIN1_HUMAN]] Defects in BIN1 are the cause of centronuclear myopathy type 2 (CNM2) [MIM:[https://omim.org/entry/255200 255200]]. A congenital muscle disorder characterized by progressive muscular weakness and wasting involving mainly limb girdle, trunk, and neck muscles. It may also affect distal muscles. Weakness may be present during childhood or adolescence or may not become evident until the third decade of life. Ptosis is a frequent clinical feature. The most prominent histopathologic features include high frequency of centrally located nuclei in muscle fibers not secondary to regeneration, radial arrangement of sarcoplasmic strands around the central nuclei, and predominance and hypotrophy of type 1 fibers.<ref>PMID:17676042</ref>
+
[https://www.uniprot.org/uniprot/BIN1_HUMAN BIN1_HUMAN] Defects in BIN1 are the cause of centronuclear myopathy type 2 (CNM2) [MIM:[https://omim.org/entry/255200 255200]. A congenital muscle disorder characterized by progressive muscular weakness and wasting involving mainly limb girdle, trunk, and neck muscles. It may also affect distal muscles. Weakness may be present during childhood or adolescence or may not become evident until the third decade of life. Ptosis is a frequent clinical feature. The most prominent histopathologic features include high frequency of centrally located nuclei in muscle fibers not secondary to regeneration, radial arrangement of sarcoplasmic strands around the central nuclei, and predominance and hypotrophy of type 1 fibers.<ref>PMID:17676042</ref>
== Function ==
== Function ==
-
[[https://www.uniprot.org/uniprot/BIN1_HUMAN BIN1_HUMAN]] May be involved in regulation of synaptic vesicle endocytosis. May act as a tumor suppressor and inhibits malignant cell transformation.
+
[https://www.uniprot.org/uniprot/BIN1_HUMAN BIN1_HUMAN] May be involved in regulation of synaptic vesicle endocytosis. May act as a tumor suppressor and inhibits malignant cell transformation.
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 24: Line 24:
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Human]]
+
[[Category: Homo sapiens]]
[[Category: Large Structures]]
[[Category: Large Structures]]
-
[[Category: Balbach, J]]
+
[[Category: Balbach J]]
-
[[Category: Loew, C]]
+
[[Category: Loew C]]
-
[[Category: Weininger, U]]
+
[[Category: Weininger U]]
-
[[Category: Alternative splicing]]
+
-
[[Category: Anti-oncogene]]
+
-
[[Category: Barpeptide]]
+
-
[[Category: Cell cycle]]
+
-
[[Category: Coiled coil]]
+
-
[[Category: Cytoplasm]]
+
-
[[Category: Developmental protein]]
+
-
[[Category: Differentiation]]
+
-
[[Category: Disease mutation]]
+
-
[[Category: Endocytosis]]
+
-
[[Category: Host-virus interaction]]
+
-
[[Category: Micelle]]
+
-
[[Category: Nmr-structure]]
+
-
[[Category: Nucleus]]
+
-
[[Category: Phosphoprotein]]
+
-
[[Category: Sh3 domain]]
+

Current revision

Structure of the N-terminal BARpeptide in DPC micelles

PDB ID 2rnd

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools